Member Info for alfista

Clearly stated in the patent that it can be derived from the whole fruit. However, the juicing industry remove the shin and seeds, so the by product could be an economical source of wstc. I did ask Steve Morrison (remember him?) but he wouldn't divulge. I do agree that the process could be carried out close to the raw material to obtain efficiencies. If they owned the patents they could do just that.

It'll be strange to no longer have this company on my Watchlist.

All a bit sordid, and a warning to investors that bigger money almost always wins.

Good to luck to the company for the sake of its workforce.

A few larger trades, massive response.

Good to see, but very hard to explain.

Yep, fact is that both countries have a middle class bigger than that of Europe. Certainly true that the difference between rich and poor is greater, but Rachel is working hard to correct that.

OK, I won't develop this thought process further, I accept that it is negative. There's a need for real information for us to discuss, rather than what could well be paranoia on my part.

I think your prediction is 100% accurate gix.

China isn't in the positive growth trend that had persisted for some 30 years, unemployment is high, and the possibility that USA will bring back manufacturing to their own shores presents a barrier to growth for the foreseeable. That's the charitable view, there is also the less charitable view as I've expressed before, that being that the delay is political. I'm not claiming to know, just making an observation based on experience.

I don't want to spark paranoia, but yes. The "we need far more than you little folks could fund, so we found this sugar daddy to take the whole shebang" scenario is a danger.

I've also made mention of China politics a few times before. A core business in other markets would be a big plus, but we don't have up to date info about sales to existing and new clients worldwide.

Silence doesn't help us. On the other hand, Blue Cap approval, and the announcement of big product launches could make all that fretting look barmy. Can but hope.

It would be interesting to know if partaking in a placing came with any tax benefit?

I won't be popular for saying this, but it's a worry that we are in maximum danger if we are at the threshold of big time turnover.

Hope we can see it through, patience deserves a reward

New, and larger stock levels will only be needed to satisfy demand from new product launches.

A very clumsy attempt at bashing, ignoring the reality. If demand stays similar, no big new production needed, no stress of finances. If By Health get approval, and launch the multiple products they have stated, big new demand, need to finance.

A very simple, demand led, decision.

A note on Winnie's site suggests that the trial is ongoing, and, more shockingly, that the four on trial are already planning a comeback. If anyone is a member of Sharepoppets, they may be able to read in more detail, I only get the headlines on an email.

It would be simple to take your Fruitflow+O3 Tab along with the yoghurt pot of drink of your choice.

Job done

Decent buy slipped in there.

Can but hope.

Sorry typos, distracted by work. That reads like officer Crabtree speak

You may just have revealed what the Youtube algo makes of your preferences ! :)

How many brands are running Fruitflow now ? What haven't they mode a splash on the socials? What's happeing to DSM and their gut health patent an applications?

AIM market is dead moody at the moment, a bad influence on all of our thinking IMHO

Welly,

The answer to your questions is, as it has always been, financial restrictions

Effect

Do tell us how that affects the outcome of a Chinese state controlled approval process.

Blethering half wit attitude.

Totally understand your rebellious mood, but don't you think hat they will already know that they have a majority. the large holders will look after themselves, caring not a jot about how smaller investors fare. It stinks, but....

Looks a done deal.

Small guy gets stitched.

The concept looked good, but the investment case didn't survive the dilution. Now that it's stable and approaching profits, snatched away at mates rates.

Are they trying to cover for someone reducing their holding? The sp action is just weird at the moment